Torri Pierce, MD
Obstetrics & Gynecology · Katy, TXNPI 1558555979
Payments from drug & device makers
Across 138 payments — averaging $22.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exeltis, USA Inc.$594
- AbbVie$469
- Gynesonics, Inc.$156
- Lupin Inc.$149
- Mayne Pharma Commercial LLC$139
- Therapeuticsmd, Inc.$124
- plus $2K from 28 others
What the payments were for
- Food & beverage$3,07997%
- Education$943%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exeltis, USA Inc. | 25 | $594 |
| AbbVie(2 entities) | 23 | $469 |
| Gynesonics, Inc. | 2 | $156 |
| Lupin Inc. | 9 | $149 |
| Mayne Pharma Commercial LLC | 9 | $139 |
| Therapeuticsmd, Inc. | 4 | $124 |
| Medical Device Business Services, Inc. | 1 | $122 |
| Astellas Pharma US Inc | 5 | $120 |
| Acessa Health Inc. | 1 | $120 |
| Johnson & Johnson | 4 | $92 |
| Avion Pharmaceuticals | 6 | $88 |
| Applied Medical Resources Corporation | 2 | $80 |
| Caldera Medical, Inc | 1 | $80 |
| Bayer | 3 | $71 |
| Myovant Sciences Inc. | 4 | $71 |
| Millicent US Inc | 4 | $67 |
| Merck | 4 | $66 |
| Sumitomo Pharma America, Inc. | 3 | $65 |
| Pfizer | 4 | $65 |
| Dexcom, Inc. | 2 | $50 |
| Hologic Sales And Service, LLC | 2 | $47 |
| Currax Pharmaceuticals LLC | 3 | $46 |
| Sage Therapeutics, LLC | 2 | $40 |
| Mission Pharmacal Company | 2 | $35 |
| Meditrina | 2 | $35 |
| Shield Therapeutics Inc | 2 | $31 |
| Exact Sciences | 1 | $24 |
| Medicem Inc. | 1 | $22 |
| Mylan Pharmaceuticals Inc. | 1 | $21 |
| Organon | 2 | $20 |
| Duchesnay USA Incorporated | 1 | $18 |
| Evofem Biosciences, Inc. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Coopersurgical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,173 in reported general payments places this provider in the 75th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 17 | $347 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Katy
- Kelly McCullaghKaty$307K
- Amir JazaeriHouston$19.5M
- Shannon WestinHouston$17.3M
- Monica LopezFort Worth$8.1M
- Cynthia RobbinsFort Worth$7.8M
- John Paul RobertsPlano$4.9M
- Stephen StamatisWeatherford$4.5M
- Parke HedgesSan Antonio$4.2M
- Mary MartinBeaumont$2.8M
- Mark JacobsHouston$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.